Nference AI technology enables knowledge synthesis from unstructured text and structured biomedical databases. It synthesizes exponentially growing biomedical knowledge to solve urgent healthcare problems. The company uses state-of-the-art neural networks for real-time, automated extraction of insights by triangulating unstructured and structured information from the biomedical literature as well as from large scale molecular and real-world datasets. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. In the last 15 years, the world has seen a massive digitization of healthcare information driven by the exponential increase and availability of scientific literature, molecular data and real world evidence. Advances in next-generation sequencing have significantly reduced the cost of sequencing and this has enabled large-scale initiatives like the UK Biobank where 500K patients have been sequenced and their de-identified clinico-genomic data is now available to scientists worldwide.
B2B
251 to 500
Series B
$74 M
Scaling Up
2015
Pharmaceuticals
Healthcare
N/A
Increase Productivity
Increase Efficiency
Analytics
IT and Security
Service
Yes
Active
Machine Learning
Natural Language Processing
Knowledge Representation and Reasoning
N/A
Software
N/A
N/A
Interested in what they do or partnership?
Learn more about how they work